BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Glaser K, Glaser W, Marino L, Ruchala M, Bilotta F. Impact of glucagon-like peptide-1 receptor agonists on the incidence of atrial fibrillation. World J Cardiol 2025; 17(7): 107510 [PMID: 40741027 DOI: 10.4330/wjc.v17.i7.107510]
URL: https://www.wjgnet.com/1949-8462/full/v17/i7/107510.htm
Number Citing Articles
1
Ling Liu, Junlin Lu. Research on epicardial adipose tissue as a metabolic therapeutic target in AF: focus on GLP-1 receptor agonistsFrontiers in Cardiovascular Medicine 2026; 13 doi: 10.3389/fcvm.2026.1708109
2
Md.Mohaimenul Islam, Arinze Nkemdirim Okere. Glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes and atrial fibrillation: a multicenter comparative effectiveness cohort study of cardiovascular and arrhythmic outcomesDiabetes Research and Clinical Practice 2026; 237 doi: 10.1016/j.diabres.2026.113346